GlassScriptPhysician profile
William A Broyles
NPI 1801839964
$471.68
in general payments reported to CMS, 2019-2025
13 companies · $79.65 in 2025
The $79.65 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $60.62 · 2022: $95.54 · 2023: $173 · 2024: $62.93 · 2025: $79.65.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $316.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $315.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $135.31 | 2022-2025 | Puraply, Affinity, Apligraf |
| Peerless Surgical INC. | $82.96 | 2023 | |
| Paratek Pharmaceuticals, INC. | $56.93 | 2022-2025 | Nuzyra |
| Melinta Therapeutics, LLC | $41.57 | 2019 | |
| Kci USA, INC. | $20.10 | 2023 | Promogran Prisma, Snap, Activ.A.C. |
| Orthopediatrics Corp. | $19.10 | 2025 | |
| Bioventus LLC | $19.07 | 2024 | Exogen Ultrasound Bone Healing System |
| Paragon 28, INC. | $19.05 | 2019 | |
| Treace Medical Concepts, INC. | $17.92 | 2022 | |
| Zimvie INC. | $15.81 | 2022 | |
| Averitas Pharma INC. | $14.97 | 2024 | Qutenza |
| Kerecis Limited | $14.64 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Orthofix Medical, INC. | $14.25 | 2024 | Physio-Stim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Broyles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.